RT Journal Article SR Electronic T1 Responsiveness in Rheumatoid Arthritis. A Report from the OMERACT 11 Ultrasound Workshop JF The Journal of Rheumatology JO J Rheumatol FD The Journal of Rheumatology SP jrheum.131084 DO 10.3899/jrheum.131084 A1 Annamaria Iagnocco A1 Esperanza Naredo A1 Richard Wakefield A1 George A.W. Bruyn A1 Paz Collado A1 Sandrine Jousse-Joulin A1 Stephanie Finzel A1 Sarah Ohrndorf A1 Andrea Delle Sedie A1 Marina Backhaus A1 Hilde Berner-Hammer A1 Frederique Gandjbakhch A1 Gurjit Kaeley A1 Damien Loeuille A1 Ingrid Moller A1 Lene Terslev A1 Philippe Aegerter A1 Sibel Aydin A1 Peter V. Balint A1 Emilio Filippucci A1 Peter Mandl A1 Carlos Pineda A1 Johannes Roth A1 Silvia Magni-Manzoni A1 Niolay Tzaribachev A1 Wolfgang A. Schmidt A1 Philip G. Conaghan A1 Maria-Antonietta D'Agostino YR 2013 UL http://www.jrheum.org/content/early/2013/11/13/jrheum.131084.abstract AB Objective To summarize the work performed by the Outcome Measures in Rheumatology (OMERACT) Ultrasound (US) Task Force on the validity of different US measures in rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) presented during the OMERACT 11 Workshop. Methods The Task Force is an international group aiming to iteratively improve the role of US in arthritis clinical trials. Recently a major focus of the group has been the assessment of responsiveness of a person-level US synovitis score in RA: the US Global Synovitis Score (US-GLOSS) combines synovial hypertrophy and power Doppler signal in a composite score detected at joint level. Work has also commenced examining assessment of tenosynovitis in RA and the role of US in JIA. Results The US-GLOSS was tested in a large RA cohort treated with biologic therapy. It showed early signs of improvement in synovitis starting at Day 7 and increasing to Month 6, and demonstrated sensitivity to change of the proposed grading. Subsequent voting questions concerning the application of the US-GLOSS were endorsed by > 80% of OMERACT delegates. A standardized US scoring system for detecting and grading severity of RA tenosynovitis and tendon damage has been developed, and acceptable reliability data were presented from a series of exercises. A preliminary consensus definition of US synovitis in pediatric arthritis has been developed and requires further testing. Conclusion At OMERACT 11, consensus was achieved on the application of the US-GLOSS for evaluating synovitis in RA; and work continues on development of RA tenosynovitis scales as well as in JIA synovitis.